+
Open data
-
Basic information
| Entry | Database: PDB / ID: 7ly2 | ||||||
|---|---|---|---|---|---|---|---|
| Title | SARS-CoV-2 S/S2M11/S2M28 Global Refinement | ||||||
 Components | 
  | ||||||
 Keywords | VIRAL PROTEIN/IMMUNE SYSTEM / Antibody / VIRAL PROTEIN / Structural Genomics / Seattle Structural Genomics Center for Infectious Disease / SSGCID / VIRAL PROTEIN-IMMUNE SYSTEM complex | ||||||
| Function / homology |  Function and homology informationsymbiont-mediated disruption of host tissue / Maturation of spike protein / Translation of Structural Proteins / Virion Assembly and Release / host cell surface / host extracellular space / viral translation / symbiont-mediated-mediated suppression of host tetherin activity / Induction of Cell-Cell Fusion / structural constituent of virion ...symbiont-mediated disruption of host tissue / Maturation of spike protein / Translation of Structural Proteins / Virion Assembly and Release / host cell surface / host extracellular space / viral translation / symbiont-mediated-mediated suppression of host tetherin activity / Induction of Cell-Cell Fusion / structural constituent of virion / entry receptor-mediated virion attachment to host cell / membrane fusion / Attachment and Entry / host cell endoplasmic reticulum-Golgi intermediate compartment membrane / positive regulation of viral entry into host cell / receptor-mediated virion attachment to host cell / host cell surface receptor binding / symbiont-mediated suppression of host innate immune response / receptor ligand activity / endocytosis involved in viral entry into host cell / fusion of virus membrane with host plasma membrane / fusion of virus membrane with host endosome membrane / viral envelope / symbiont entry into host cell / virion attachment to host cell / SARS-CoV-2 activates/modulates innate and adaptive immune responses / host cell plasma membrane / virion membrane / identical protein binding / membrane / plasma membrane Similarity search - Function  | ||||||
| Biological species | ![]()  Homo sapiens (human) | ||||||
| Method | ELECTRON MICROSCOPY / single particle reconstruction / cryo EM / Resolution: 2.5 Å | ||||||
 Authors | McCallum, M. / Veesler, D. / Seattle Structural Genomics Center for Infectious Disease (SSGCID) | ||||||
| Funding support |   United States, 1items 
  | ||||||
 Citation |  Journal: Cell / Year: 2021Title: N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2. Authors: Matthew McCallum / Anna De Marco / Florian A Lempp / M Alejandra Tortorici / Dora Pinto / Alexandra C Walls / Martina Beltramello / Alex Chen / Zhuoming Liu / Fabrizia Zatta / Samantha ...Authors: Matthew McCallum / Anna De Marco / Florian A Lempp / M Alejandra Tortorici / Dora Pinto / Alexandra C Walls / Martina Beltramello / Alex Chen / Zhuoming Liu / Fabrizia Zatta / Samantha Zepeda / Julia di Iulio / John E Bowen / Martin Montiel-Ruiz / Jiayi Zhou / Laura E Rosen / Siro Bianchi / Barbara Guarino / Chiara Silacci Fregni / Rana Abdelnabi / Shi-Yan Caroline Foo / Paul W Rothlauf / Louis-Marie Bloyet / Fabio Benigni / Elisabetta Cameroni / Johan Neyts / Agostino Riva / Gyorgy Snell / Amalio Telenti / Sean P J Whelan / Herbert W Virgin / Davide Corti / Matteo Samuele Pizzuto / David Veesler /         ![]() Abstract: The SARS-CoV-2 spike (S) glycoprotein contains an immunodominant receptor-binding domain (RBD) targeted by most neutralizing antibodies (Abs) in COVID-19 patient plasma. Little is known about ...The SARS-CoV-2 spike (S) glycoprotein contains an immunodominant receptor-binding domain (RBD) targeted by most neutralizing antibodies (Abs) in COVID-19 patient plasma. Little is known about neutralizing Abs binding to epitopes outside the RBD and their contribution to protection. Here, we describe 41 human monoclonal Abs (mAbs) derived from memory B cells, which recognize the SARS-CoV-2 S N-terminal domain (NTD) and show that a subset of them neutralize SARS-CoV-2 ultrapotently. We define an antigenic map of the SARS-CoV-2 NTD and identify a supersite (designated site i) recognized by all known NTD-specific neutralizing mAbs. These mAbs inhibit cell-to-cell fusion, activate effector functions, and protect Syrian hamsters from SARS-CoV-2 challenge, albeit selecting escape mutants in some animals. Indeed, several SARS-CoV-2 variants, including the B.1.1.7, B.1.351, and P.1 lineages, harbor frequent mutations within the NTD supersite, suggesting ongoing selective pressure and the importance of NTD-specific neutralizing mAbs for protective immunity and vaccine design.  | ||||||
| History | 
  | 
-
Structure visualization
| Movie | 
 
 
  Movie viewer | 
|---|---|
| Structure viewer | Molecule:  Molmil Jmol/JSmol | 
-
Downloads & links
-
Download
| PDBx/mmCIF format |  7ly2.cif.gz | 832 KB | Display |  PDBx/mmCIF format | 
|---|---|---|---|---|
| PDB format |  pdb7ly2.ent.gz | 659.8 KB | Display |  PDB format | 
| PDBx/mmJSON format |  7ly2.json.gz | Tree view |  PDBx/mmJSON format | |
| Others |  Other downloads | 
-Validation report
| Summary document |  7ly2_validation.pdf.gz | 3.4 MB | Display |  wwPDB validaton report | 
|---|---|---|---|---|
| Full document |  7ly2_full_validation.pdf.gz | 3.4 MB | Display | |
| Data in XML |  7ly2_validation.xml.gz | 111.9 KB | Display | |
| Data in CIF |  7ly2_validation.cif.gz | 177.1 KB | Display | |
| Arichive directory |  https://data.pdbj.org/pub/pdb/validation_reports/ly/7ly2 ftp://data.pdbj.org/pub/pdb/validation_reports/ly/7ly2 | HTTPS FTP  | 
-Related structure data
| Related structure data | ![]() 23582MC ![]() 7lxwC ![]() 7lxxC ![]() 7lxyC ![]() 7lxzC ![]() 7ly0C ![]() 7ly3C M: map data used to model this data C: citing same article (  | 
|---|---|
| Similar structure data | 
-
Links
-
Assembly
| Deposited unit | ![]() 
  | 
|---|---|
| 1 | 
  | 
-
Components
-Protein , 1 types, 3 molecules ABJ  
| #1: Protein | Mass: 142427.438 Da / Num. of mol.: 3 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() Gene: S, 2 / Production host:  Homo sapiens (human) / References: UniProt: P0DTC2 | 
|---|
-Antibody , 4 types, 12 molecules DCKEFMHGNLIO           
| #2: Antibody | Mass: 11208.458 Da / Num. of mol.: 3 Source method: isolated from a genetically manipulated source Source: (gene. exp.)  Homo sapiens (human) / Production host:  Homo sapiens (human)#3: Antibody | Mass: 13651.220 Da / Num. of mol.: 3 Source method: isolated from a genetically manipulated source Source: (gene. exp.)  Homo sapiens (human) / Production host:  Homo sapiens (human)#4: Antibody | Mass: 13097.583 Da / Num. of mol.: 3 Source method: isolated from a genetically manipulated source Source: (gene. exp.)  Homo sapiens (human) / Production host:  Homo sapiens (human)#5: Antibody | Mass: 11323.427 Da / Num. of mol.: 3 Source method: isolated from a genetically manipulated source Source: (gene. exp.)  Homo sapiens (human) / Production host:  Homo sapiens (human) | 
|---|
-Sugars , 3 types, 54 molecules 
| #6: Polysaccharide | Source method: isolated from a genetically manipulated source #7: Polysaccharide | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Source method: isolated from a genetically manipulated source #8: Sugar | ChemComp-NAG /  | 
|---|
-Details
| Has ligand of interest | Y | 
|---|---|
| Has protein modification | Y | 
-Experimental details
-Experiment
| Experiment | Method: ELECTRON MICROSCOPY | 
|---|---|
| EM experiment | Aggregation state: PARTICLE / 3D reconstruction method: single particle reconstruction | 
-
Sample preparation
| Component | Name: SARS-CoV-2 S hexapro bound to S2M11 and S2M28 Fabs / Type: COMPLEX / Entity ID: #1-#5 / Source: RECOMBINANT | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular weight | Experimental value: NO | ||||||||||||
| Source (natural) | 
  | ||||||||||||
| Source (recombinant) | Organism:  Homo sapiens (human) | ||||||||||||
| Buffer solution | pH: 8 | ||||||||||||
| Specimen | Embedding applied: NO / Shadowing applied: NO / Staining applied: NO / Vitrification applied: YES | ||||||||||||
| Vitrification | Cryogen name: ETHANE | 
-
Electron microscopy imaging
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company  | 
|---|---|
| Microscopy | Model: FEI TITAN KRIOS | 
| Electron gun | Electron source:  FIELD EMISSION GUN / Accelerating voltage: 300 kV / Illumination mode: FLOOD BEAM | 
| Electron lens | Mode: BRIGHT FIELD | 
| Image recording | Electron dose: 60 e/Å2 / Detector mode: COUNTING / Film or detector model: GATAN K2 SUMMIT (4k x 4k) | 
-
Processing
| CTF correction | Type: PHASE FLIPPING AND AMPLITUDE CORRECTION | 
|---|---|
| 3D reconstruction | Resolution: 2.5 Å / Resolution method: FSC 0.143 CUT-OFF / Num. of particles: 221993 / Symmetry type: POINT | 
Movie
Controller
About Yorodumi





Homo sapiens (human)
United States, 1items 
Citation
 
 
 
UCSF Chimera





















PDBj






